On May 25, 2022, NOWDiagnostics was granted CE Mark for the ADEXUSDx® Syphilis rapid test.  This treponemal assay requires only 1 drop of whole blood to perform and yields a laboratory quality result in just 15 minutes.  The test has 100% sensitivity for al...

NOWDiagnostics, Inc. announced today that it has filed for expanded Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) of the ADEXUSDx® COVID-19 antibody test for point-of-care (POC)/CLIA waived testing. A prospective clinica...

Jim Haworth is a proven executive with a 37-year background as Chairman, Board Member, and CEO in the direction, leadership and implementation of business operations, merchandising and marketing solutions, including: strategic planning, financial structurin...

University of Milan Study Finds Self-Contained, Rapid ADEXUSDx® COVID-19 Antibody Test has 100 Specificity Independent study confirms revolutionary technology provides accurate results in minutes while requiring no additional reagents or equipment. SPRINGD...

The American Pharmacists Association Foundation (APhA Foundation) and NOWDiagnostics, Inc., a Springdale-based leader in innovative diagnostics testing, today announced that NOWDiagnostics’ ADEXUSDx® COVID-19 antibody test, a rapid-results self-contained fi...

NOWDiagnostics, Inc. announced today that it has received Emergency Use Authorization (EUA) for its ADEXUSDx® COVID-19 antibody test for use at the point-of-care from the U.S. Food and Drug Administration (FDA). Following today’s EUA, NOWDiagnostics will b...